Valuation: Haleon plc

Market Cap 31.99B 43.6B 37.34B 34.94B 60.03B 4,171B 60.82B 413B 161B 2,095B 164B 160B 6,931B P/E 2026 *
18.9x
P/E 2027 * 16.7x
Enterprise Value 38.85B 52.95B 45.36B 42.44B 72.91B 5,066B 73.87B 501B 196B 2,545B 199B 195B 8,418B EV / Sales 2026 *
3.41x
EV / Sales 2027 * 3.24x
Free-Float
98.46%
Yield 2026 *
2.23%
Yield 2027 * 2.47%
1 day+0.89%
1 week+2.11%
Current month-0.06%
1 month-1.49%
3 months+6.08%
6 months-11.33%
Current year-3.12%
1 week 348.8
Extreme 348.8
363.5
1 month 348.8
Extreme 348.8
384.2
Current year 317.8
Extreme 317.8
416.1
1 year 274.4
Extreme 274.4
416.1
3 years 274.4
Extreme 274.4
419.5
5 years 241.17
Extreme 241.1735
419.5
10 years 241.17
Extreme 241.1735
419.5
Manager TitleAgeSince
Chief Executive Officer 59 2021-07-21
Director of Finance/CFO 57 2024-10-31
Chief Tech/Sci/R&D Officer 63 2025-07-31
Director TitleAgeSince
Director/Board Member 59 2022-05-22
Chairman 71 2025-12-31
Director/Board Member 59 2022-07-17
Date Insider Type Main position Quantity % Market Cap.
6/30/26 Free

Chief Financial Officer

283,193 0.0032%
6/30/26 Tax

Chief Financial Officer

-133,301 0.0015%
2/12/26 Free

General Counsel

31 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
+0.89%+2.11%-0.74%+12.82% 43.6B
+0.88%+6.38%+76.86%+128.23% 1,119B
+1.07%+3.80%+51.03%+61.48% 651B
+1.20%+6.21%+26.47%+76.45% 468B
+1.02%+5.77%+43.09%+47.70% 374B
+0.85%+4.07%+23.88%+41.58% 302B
+1.26%+6.81%+1.59%+14.67% 259B
+1.88%+5.81%+48.54%+68.52% 238B
+1.59%+2.09%-15.52%-52.29% 208B
+1.87%+5.61%+25.81%+92.42% 181B
Average +1.25%+4.69%+28.10%+49.16% 384.35B
Weighted average by Cap. +1.13%+5.06%+43.80%+71.87%

Financials

2026 *2027 *
Net sales 11.39B 15.53B 13.3B 12.45B 21.38B 1,486B 21.66B 147B 57.34B 746B 58.3B 57.03B 2,468B 11.87B 16.18B 13.86B 12.97B 22.28B 1,548B 22.58B 153B 59.76B 778B 60.76B 59.44B 2,573B
Net income 1.7B 2.31B 1.98B 1.85B 3.18B 221B 3.23B 21.9B 8.54B 111B 8.68B 8.5B 368B 1.92B 2.62B 2.24B 2.1B 3.6B 250B 3.65B 24.79B 9.67B 126B 9.83B 9.62B 416B
Net Debt 6.86B 9.36B 8.01B 7.5B 12.88B 895B 13.05B 88.6B 34.55B 450B 35.13B 34.37B 1,487B 6.42B 8.76B 7.5B 7.02B 12.06B 838B 12.22B 82.92B 32.34B 421B 32.88B 32.16B 1,392B
Logo Haleon plc
Haleon plc specializes in the research, manufacture and marketing of drugs and consumer pharmaceutical products. Net sales break down by family of products as follows: - oral health products (31.4%; no. 1 worldwide): Sensodyne, Parodontax, Polident, Biotene, Aquafresh brands, etc.; - pain relief medicines (23.2%; no. 1 worldwide): Panadol, Advil, Voltaren, Excedrin brands, etc.; - respiratory medicines (17%; no. 1 worldwide): Theraflu, Otrivin, Flonase, Contac brands, etc.; - vitamins, minerals and food supplements (15.3%; no. 1 worldwide): Centrum, Emergen-C, Caltrate brands, etc.; - medicines for digestive health (8.9%; no. 1 worldwide): TUMS, Nicorette, ENO, Chap Stick, Fenistil, Nexium brands, etc.; - other (4.2%). Net sales are distributed geographically as follows: Europe/Middle East/Africa/Latin America (41.6%), North America (35.1%), and Asia/Pacific (23.3%).
Employees
24,535
Date Price Change Volume
26-08-21 GBX 363.10 +0.89% 14,337,114
26-08-20 GBX 359.90 +0.56% 20,882,955
26-08-19 GBX 357.90 +0.65% 23,666,803
26-08-18 GBX 355.60 +1.54% 21,852,263
26-08-17 GBX 350.20 -1.52% 11,334,933
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
3.631GBP
Average target price
4.208GBP
Spread / Average Target
+15.90%

Quarterly revenue - Rate of surprise